1-2 sterilisationvalidationqualification (1)
TRANSCRIPT
-
7/26/2019 1-2 SterilisationValidationQualification (1)
1/49
Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%1
Sterilization - validation,
qualification requirements
Mrs Robyn Isaacson
-
7/26/2019 1-2 SterilisationValidationQualification (1)
2/49
Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%2
Sterilization - Overview
Objectives Discuss definition of Sterile
!riefly describe sterilization met"ods
Describe a##roac"es to be used for t"e
validation of a sterilization #rocess usin$Moist %eat as an e&am#le
Describe requirements for routine monitorin$
and control of sterilization
Review issues t"at are s#ecific to ot"ersterilization #rocesses
-
7/26/2019 1-2 SterilisationValidationQualification (1)
3/49
Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%3
Sterile 'roducts - Overview
(ertain #"armaceutical #roducts must be sterile
injections, o#"t"almic #re#arations, irri$ations solutions,
"aemodialysis solutions
)wo cate$ories of sterile #roducts
t"ose t"at can be sterilised in final container *terminally
sterilised+
t"ose t"at cannot be terminally sterilised and must be
ase#tically #re#ared
-
7/26/2019 1-2 SterilisationValidationQualification (1)
4/49
Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%4
Sterilization - Overview
"at is t"e definition of sterile
.ree from microor$anisms
In #ractice no suc" absolute statement re$ardin$ absence
of microor$anisms can be #roven
Defined as t"e #robability of / in a million of a
container bein$ contaminated */0-1+
)"is referred to as t"e Sterility 2ssurance 3evel
*S23+
Or$anisms are 4illed in an eonential fas"ion
-
7/26/2019 1-2 SterilisationValidationQualification (1)
5/49
Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%5
Definition of Sterile
MI(RO!I23 I52()I62)IO5
5t7 5oe
-4t
0
200
400
600
800
1000
1200
)ime
5oofsurvivin$or$anisms
-2.00
-1.50
-1.00
-0.50
0.00
0.50
1.00
1.50
2.00
2.50
3.00
3.50
No remaining
Log No remaining
No remaining 1000 368 135 50 18 7 2 1 0 0 0
Log No remaining 3.00 2.57 2.13 1.70 1.26 0.83 0.39 -0.04 -0.47 -0.91 -1.34
0 1 2 3 4 5 6 7 8 9 10
-
7/26/2019 1-2 SterilisationValidationQualification (1)
6/49
Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%6
Definition of Sterile
D-value - )ime *or dose+ required to reduce t"e#o#ulation of or$anisms by / lo$ *or 809+
D-Value
Resistance of an or$anism is referred as its D-value
-
7/26/2019 1-2 SterilisationValidationQualification (1)
7/49
Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%7
Definition of Sterile
2 sterilization #rocess must deliver a
Sterility 2ssurance 3evel *S23+ of / in a
million */0-1+
It is not #ossible to measure /0-1
)"e required S23 can be ac"ieved by
a##lyin$ a #rocess t"at will reduce t"e
number of or$anisms to zero and t"ena##ly a safety factor t"at will deliver an
e&tra 1 lo$ reduction
-
7/26/2019 1-2 SterilisationValidationQualification (1)
8/49
Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%8
Definition of Sterile
:&am#le
.or an initial bioburden of /0; t"e
sterilization #rocess will need to
ac"ieve an < lo$ reduction in
viable or$anisms
)"is will require < times t"e D-
value *e=$= if t"e or$anism "as a
D value of ; minutes t"en < & ; 7
/1 minutes will be required to
ac"ieve an < lo$ reduction andan S23 of /0-1+ *'oint >+
-
7/26/2019 1-2 SterilisationValidationQualification (1)
9/49
Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%9
Sterilization - Overview
(ommonly used met"ods of sterilization Moist %eat
Dry %eat
?as *:t"ylene o&ide+
Radiation *?amma or :lectron+
.iltration
Ot"ers - @6, Steam and formalde"yde,
"ydro$en #ero&ide
-
7/26/2019 1-2 SterilisationValidationQualification (1)
10/49
Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%10
Moist %eat Saturated steam
(ommon cyclesA /;/B( for /C minutes
/EB( for minutes
Ot"er cycles of lower tem#erature and lon$ertime may be used *e=$= //CB( for 0 minutes+
@sed for sterilization ofA
terminal sterilization of aqueous injections,
o#"t"almic #re#arations, irri$ation F"aemodialysis solutions, equi#ment used in
ase#tic #rocessin$
-
7/26/2019 1-2 SterilisationValidationQualification (1)
11/49
Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%11
Moist %eat
not suitable for non-aqueousGdry
#re#arations
#referred met"od of sterilization
-
7/26/2019 1-2 SterilisationValidationQualification (1)
12/49
Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%12
Dry %eat
3et"ality due to o&idative #rocesses %i$"er tem#eratures and lon$er eosure
times required
)y#ical cyclesA
/10B( for /;0 minutes
/H0B( for 10 minutes
/
-
7/26/2019 1-2 SterilisationValidationQualification (1)
13/49
Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%13
Dry %eat
@sed forA
$lassware and #roduct containers used in
ase#tic manufacture, non aqueous
t"ermostable #owders and liquids *oils+
also used for de#yro$enation of $lassware*
;C0B(+
*'yro$ens - substances found in cell wall of
some bacteria w"ic" can cause fever w"en
introduced into t"e body+
-
7/26/2019 1-2 SterilisationValidationQualification (1)
14/49
Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%14
:t"ylene O&ide ?as
:it"er #ure or in mi&tures wit" ot"er inert$ases
Requires #resence of moisture
(om#le& #rocess
)y#ical cyclesA
/-;E"ours
;C-/;00 m$G3 $as
;C-1CB( 0-
-
7/26/2019 1-2 SterilisationValidationQualification (1)
15/49
Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%15
:t"ylene O&ide @sed forA
"eat labile #roduct containers
surface sterilization of #owders
2dequate aeration to reduce to&ic
residues
-
7/26/2019 1-2 SterilisationValidationQualification (1)
16/49
Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%16
Radiation
?amma rays $enerated by (obalt 10 or (aesium/H radionuclides or
2ccelerated electrons from an electron $enerator
;C 4ilo$rays *4?y+ usual dose
dose de#endent on bioburden *resistance of or$anismsnot #redictable+
#rocess must be #ro#erly validated
used forA
dry #"armaceutical #roducts "eat labile #roduct containers
can cause unacce#table c"an$es
-
7/26/2019 1-2 SterilisationValidationQualification (1)
17/49
Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%17
.iltration
Removes or$anisms from liquids and$asses
0=; - 0=;; micron for sterilization
com#osed of cellulose esters or ot"er
#olymeric materials
filter material must be com#atible wit"
liquid bein$ filtered
used for bul4 liquids, $asses and ventfilters
-
7/26/2019 1-2 SterilisationValidationQualification (1)
18/49
Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%18
6alidation - Overview
Selection of sterilzation #rocess must be
a##ro#riate for #roduct
terminal sterilization is t"e met"od of c"oice
moist "eat *autoclavin$+ is t"e most common
#rocess used for terminal sterilization #roduct must not be affected by "eat
containerGclosure inte$rity must be establis"ed
items bein$ sterilised must contain water *if
sealed+ or material must allow for removal ofair and #enetration of steam for steam *moist
"eat+ sterilization
-
7/26/2019 1-2 SterilisationValidationQualification (1)
19/49
Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%19
6alidation - 'rotocol
Requirements for Moist %eat SterilizationOt"er #rocesses follow similar requirements
6alidation #rotocol s"ould include t"e
followin$ details for eac" sterilization
#rocess #rocess objectives in terms of #roduct ty#e,containerGclosure system, S23 required
s#ecifications for time, tem#erature, #ressure
and loadin$ #attern descri#tion of all equi#ment and su##ort
systems in terms of ty#e, model, ca#acity and
o#eratin$ ran$e
-
7/26/2019 1-2 SterilisationValidationQualification (1)
20/49
Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%20
6alidation - 'rotocol
Moist %eat continuedA
#erformance c"aracteristics of all equi#ment e=$=
#ressure $au$es, valves, alarm systems, timers,
steam flow ratesG#ressures, coolin$ water flow
rates, cycle controller functions, door closure
$as4etin$ and air brea4 systems and filters met"odolo$y for monitorin$ #erformance of
equi#ment and t"e #rocess and labatory testin$
met"odolo$y
#ersonnel res#onsible for all sta$es and finalevaluation *s"ould "ave eerience and
necessary trainin$ and be aut"orized+
-
7/26/2019 1-2 SterilisationValidationQualification (1)
21/49
Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%21
6alidation - (alibration
3aboratory testin$ s"ould be #erformed by a
com#etent laboratory, met"odolo$y s"ould
be documented
2ll instruments must be calibrated e=$=
tem#erature recorders and sensors t"ermocou#les
#ressure sensors for jac4et and c"amber
timers
conductivity monitors for coolin$ water
flow metres for waterGsteam water level indicators w"en coolin$ water is used
t"ermometers includin$ t"ose for t"ermocou#le reference,
c"amber monitorin$ and laboratory testin$
-
7/26/2019 1-2 SterilisationValidationQualification (1)
22/49
Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%22
6alidation - (alibration Indicators s"ould be calibrated
#"ysical and c"emcial indicators s"ould be testedto demonstrate acce#table res#onse to time and
tem#erature
biolo$ical indicators s"ould be tested for count and
timeGtem#erature eosure res#onse
for commercial indicators - test certificate wit" countand D-value and eosure res#onse s"ould be
available= Results acce#table if verified in "ouse
#eriodically=
In "ouse indicators must be fully c"aracterized *D-
value, identification+ and a##ro#riate for sterilization#rocess
2ll indicators s"ould be a##ro#riately stored and
wit"in eiry
-
7/26/2019 1-2 SterilisationValidationQualification (1)
23/49
Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%23
6alidation - (ycle Develo#ment
(once#t of .o
3et"ality factor equivalent to time at /;/B( / minute at /;/B( is equivalent to .o of /=
3et"ality can accumulate durin$ "eat u# and cooldown #"ases
Typical temperatre pro!ile o! a "eat #terili$ation proce##
%"at &ol' (e t"e )o o! a cycle at 121*+ !or 15 minte#,
-
7/26/2019 1-2 SterilisationValidationQualification (1)
24/49
Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%24
6alidation - (ycle Develo#ment
.o is calculated usin$ t"e followin$
equationA
.o7 JtK/0*)-/;/G>+
w"ereA
Jt is t"e time interval between measurements oftem#erature *)+
) is t"e tem#erature of sterilised #roduct at time *t+
> is a tem#erature coefficient w"ic" measures t"e
number of de$rees required to c"an$e t"e D-value of
an or$anism by / lo$
-
7/26/2019 1-2 SterilisationValidationQualification (1)
25/49
Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%25
6alidation - (ycle Develo#ment
)"e minimum .o required by a sterilzation
#rocess is related to t"e resistance of t"e
bioburden *D-value+
.o7 D/;/*3o$2 - 3o$ !+
w"ereA D/;/ is equal to t"e time at /;/B( to reduce t"e
#o#ulation of t"e most resistant or$anism in eac"
#roduct container by 809 *or / lo$+
2 is t"e number of microo$anisms #er container ! is t"e ma&imum acce#table #robability of
survival *Sterility 2ssurance 3evel , /0-1+
-
7/26/2019 1-2 SterilisationValidationQualification (1)
26/49
Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%26
6alidation - (ycle Develo#ment
)wo a##roac"es to sterilization Over4ill
'robability of survival
Over4ill a##roac" used w"en t"e #roduct
can wit"stand e&cessive "eat treatment
wit"out adverse effects
(ycle s"ould deliver an .oof at least /;
)"is will ac"ieve a /; lo$ reduction of microor$anisms
wit" a D-value of / minute
*2ssumin$ eac" #roduct unit contains /01or$anisms a /; lo$reduction will result in /0-1or$anisms #er unit or #robability
of survival *S23+ of / in a million+
*5ormal bioburden is usually muc" lower and t"e or$anisms
normally muc" less resistant t"an t"is+
-
7/26/2019 1-2 SterilisationValidationQualification (1)
27/49
Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%27
6alidation - (ycle Develo#ment!iolo$ical Indicators
device consistin$ of a 4nown number of
microor$anisms, of a 4nown resistance to a
#articular sterilization #rocess in or on a carrier
and enclosed in a #rotective #ac4a$e=
Or$anisms are in t"e form of endos#ores *not
ve$etative state+ as t"ese are most resistant tosterilization
-
7/26/2019 1-2 SterilisationValidationQualification (1)
28/49
Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%28
6alidation - (ycle Develo#mentS#ore Stri#s - a narrow stri# of
fibrous #a#er im#re$nated wit" a
bacterial s#ore sus#ension
contained in a $lassine envelo#e
S#ore Dots - (ircular #ieces offibrous #a#er im#re$nated wit"
t"e s#ore sus#ension
S#ore Sus#ensions- #ure s#oresus#ension of t"e desired
c"allen$e or$anism w"ic" can be
inocluated onto t"e surface of a
material
Self contained units containin$ s#ore
stri#s or sus#ensions and t"e
media in w"ic" t"ey are to be
incubated *sim#leGconvenient to
use+
-
7/26/2019 1-2 SterilisationValidationQualification (1)
29/49
Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%29
6alidation - (ycle Develo#ment 'robability of Survival a##roac" used used
for "eat labile #roducts)"e #rocess is validated to
ac"ieve a destruction of t"e
#resterilization bioburden to
a level of /00*'oint L+, wit" a
minimum safety factor of anadditional si&-lo$ reduction
*'oint >+
Determination of t"e
minimum .o
required is based
on t"e bioburden and its "eat
resistance
"at .owould be required for a bioburden of /0;*/00+ if D-value was /
-
7/26/2019 1-2 SterilisationValidationQualification (1)
30/49
Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%30
6alidation of Sterilization
!asic 'rinci#les
Installation ualification *I+
:nsurin$ equi#ment is installed as #er
manufacturerNs s#ecification
O#eration ualification *O+ :nsurin$ equi#ment, critical control equi#mentand instrumentation are ca#able of o#eratin$
wit"in required #arameters
'erformance ualifcation *'+ Demonstratin$ t"at sterilizin$ conditions are
ac"ieved in all #arts of sterilization load
'"ysical and microbiolo$ical
-
7/26/2019 1-2 SterilisationValidationQualification (1)
31/49
Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%31
6alidation - :qui#ment
Installation ualification
:nsurin$ equi#ment is installed as #er
manufacturerNs s#ecification
considerations for new and e&istin$ equi#ment
s#ecifications for t"e ty#e of autoclave,construction materials, #ower su##lies and
su##ort services, alarm and monitorin$
systems wit" tolerances and accuracy
requirements for e&istin$ equi#ment documented evidence
t"at t"e equi#ment can meet #rocess
s#ecifications
-
7/26/2019 1-2 SterilisationValidationQualification (1)
32/49
Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%32
6alidation - :qui#ment
O#erational ualification
:nsurin$ equi#ment, critical control
equi#ment and instrumentation are ca#able
of o#eratin$ wit"in required #arameters
)"ree or more test runs w"ic" demonstrate controls, alarms, monitorin$ devices and o#eration
indicators function
c"amber #ressure inte$rity is maintained
c"amber vacuum is maintained *if a##licable+
written #rocedures accurately reflect equi#ment o#eration
#re-set o#eration #arameters are attained for eac" run
6 lid i ' f
-
7/26/2019 1-2 SterilisationValidationQualification (1)
33/49
Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%33
6alidation - 'erformance
'erformance ualification
Demonstratin$ t"at sterilizin$ conditions are
ac"ieved in all #arts of sterilization load
'"ysicaland microbiolo$ical
'"ysical %eat distribution studies on em#ty c"amber
ma&imum and minimum cycle times and tem#eratures
to identify "eat distribution #atterns includin$ slowest
"eatin$ #oints
mulit#le tem#erature sensin$ devices s"ould be used
*t"ermocou#les+
location of devices s"ould be documented and ensure t"at
"eat distribution is uniform
6 lid ti ' f
-
7/26/2019 1-2 SterilisationValidationQualification (1)
34/49
Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%34
6alidation - 'erformance
'erformance ualification - '"ysical *;+
%eat distribution of ma&imum and minimum
c"amber load confi$urations
multi#le t"ermocou#les t"rou$"out c"amber *not inside
#roduct containers+ to determine effect of load
confi$uration on tem#erature distribution tem#erature distribution for all loads usin$ all container
sizes used in #roduction s"ould be tested
#osition of t"ermocou#les s"ould be documented
Slowest to "eatGcold s#ots in eac" run s"ould be
documented, inlcudin$ t"e drain re#eat runs s"ould be #erformed to c"ec4 variability
tem#erature distribution #rofile for eac" c"amber load
confi$uration s"ould be documented
6 lid ti ' f
-
7/26/2019 1-2 SterilisationValidationQualification (1)
35/49
Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%35
6alidation - 'erformance
'erformance ualification - '"ysical *+
%eat #enetration studies to detect t"e ma&imumand minimum tem#erature wit"in all loads
all #arts of eac" load must be on contact wit" steam
need to determine lowest and "i$"est tem#erature
locations and slowest and fastest to "eat locations
*measured inside #roduct containers+
need to consider all variables suc" as container size,
desi$n, material, viscosity of solution and fill volume=
(ontainer wit" ma&imum fill volume and slowest to "eat
solution s"ould be used
ma&imum and minimum load confi$urations for eac"
sterilization cycle usin$ routine cycle #arameters
6 lid ti ' f
-
7/26/2019 1-2 SterilisationValidationQualification (1)
36/49
Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%36
6alidation - 'erformance
'erformance ualification - '"ysical *E+
%eat #enetration *;+ May be necessary for container ma##in$ for lar$er
volumes - cold s#ot t"en used for #enetration studies
5eed to consider effects of #ac4a$in$ e=$=
overwra##in$
)"ree runs #erformed once cold s#ots "ave been
identified to demonstrate re#roducibility
6 lid ti ' f
-
7/26/2019 1-2 SterilisationValidationQualification (1)
37/49
Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%37
6alidation - 'erformance
'erformance ualification - Microbiolo$ical
!iolo$ical c"allen$e studies used w"en 'robability of Survival a##roac" is used
may not be necessary w"en cycle is /;/B( for /C minutes
*e&ce#t @S and 2ustralia+
biolo$ical indicators *!I+ containin$ s#ores of Geobacillusstearothermophilusare most commonly used *considered
worst case+= !Is containin$ ot"er or$anisms may be used
#erformance studies based on #roduct bioburden require a
considerable amount of wor4
indicators s"ould be #laced t"rou$"out t"e load, adjacent to
t"ermocou#les, at cold s#ots and slowest to "eat locations
*identified durin$ "eat #enetration studies+
any $rowt" is unacce#table unless #rocessin$ errors
demonsrated
6 lid ti ' f
-
7/26/2019 1-2 SterilisationValidationQualification (1)
38/49
Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%38
6alidation - 'erformance
6alidation re#ort must demonstrate requirements
in 6alidation #rotocol "ave been met, anydeviations must be justified
Requalification must be re#eated on an annual
basis *usually one run is acce#table+
2ny c"an$es or modifications must be evaluated
may just require requalification
any c"an$es to loadin$ #atterns, new containerGclosure
systems or cycle #arameters require full validation
R ti ' d ti
-
7/26/2019 1-2 SterilisationValidationQualification (1)
39/49
Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%39
Routine 'roduction
Issues considered for routine #roduction
Manufacturin$ environment s"ould be controlled
'rocedures in #lace to minimize t"e #re-
sterilization bioburden
bioburden limits s#ecified *alt"ou$" not so im#ortant
w"en over4ill cycle used+
)ime between fillin$ and sterilization s"ould be
s#ecified
Inte$rity of containerGclosure system s"ould be
#eriodically verified 'eriodic lea4 testin$ of c"amber *if vacuum is #art
of cycle+
R ti ' d ti
-
7/26/2019 1-2 SterilisationValidationQualification (1)
40/49
Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%40
Routine 'roduction
(oolin$ water s"ould be sterile
Differentiation between sterilized and not-yet
sterilized #roduct
'"ysical se#aration *double ended autoclave+
3abellin$ and use of visual indicators *e=$
autoclave ta#e+
'eriodic testin$ of containers to verify inte$rity of
containerGclosure system
uality of steam s"ould be defined and
#eriodically tested for contaminants
R ti ' d ti
-
7/26/2019 1-2 SterilisationValidationQualification (1)
41/49
Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%41
Routine 'roduction
:ac" sterilization cycle must be monitored
tem#erature, time and #ressure recorded
tem#erature recorder inde#endent from cycle
controller
second inde#endent tem#erature recorder drain tem#erature s"ould be recorded
c"emical and biolol$ical indicators *if
a##licable+
Sterilisation cycle records s"ould form
#art of batc" records
Ot" St ili ti '
-
7/26/2019 1-2 SterilisationValidationQualification (1)
42/49
Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%42
Ot"er Sterilization 'rocesses
Sterilization usin$ ot"er #rocesses s"ould
follow a similar a##roac" as t"at
described for moist "eat
6alidation #rotocol
:qui#ment calibration Determinin$ t"e #rocess t"at will deliver t"e
desired S23 */0-1+
I, O, '
Requirements for routine monitorin$ andcontrol
Ot" St ili ti '
-
7/26/2019 1-2 SterilisationValidationQualification (1)
43/49
Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%43
Ot"er Sterilization 'rocesses
Dry %eat
S"ould "ave air circulation in t"e c"amber
'ositive #ressure in t"e c"amber to #revent
entry of non-sterile air
%:'2 filtered air su##lied !iolo$ical indicators containin$ Bacillus
atropheus *if used+
removal of endoto&in is usually sufficient
"en removin$ #yro$ens need to validate#rocess usin$ c"allen$e tests
Ot"er Sterili ation 'rocesses
-
7/26/2019 1-2 SterilisationValidationQualification (1)
44/49
Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%44
Ot"er Sterilization 'rocesses
Radiation
@sually #erformed by contractin$ service
*need to ensure validation status,
res#onsibilities+
!ased on bioburden of #roduct bein$
sterilised
!iolo$ical indicators may be used as additional
control but may not be as resistant as naturally
occurin$ bioburden
Met"od defined in International Standard ISO///H
Ot"er Sterilization 'rocesses
-
7/26/2019 1-2 SterilisationValidationQualification (1)
45/49
Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%45
Ot"er Sterilization 'rocesses
Radiaton *;+
(orrect dose of radiation *P;C 4?y+ received
by all #roducts *measured wit" dosimeters+
quantitative measurement
number, location, wit"in calibration time-limit
Radiation sensitive colour discs a##lied to
#ac4a$in$
#rocedures to distin$uis" irradiated and non-
irradiated materials
6ariation in density of #ac4a$in$ s"ould be
addressed durin$ validation
Ot"er Sterilization 'rocesses
-
7/26/2019 1-2 SterilisationValidationQualification (1)
46/49
Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%46
Ot"er Sterilization 'rocesses
?asses and .umi$ants
e=$= et"ylene o&ide, "ydro$en #ero&ide va#our
Only w"en no ot"er met"od is suitable
Must demonstrate t"at #rocess does not
adversely affect #roduct 'ac4a$in$ must be able to #ermit in$ress of
$as and "umidity
:nsure #roduct load is adequately "eated and
"umidified #rior to sterilization *calledconditionnin$+
need to ta4e into account validation #erformed in
summer or winter
Ot"er Sterilization 'rocesses
-
7/26/2019 1-2 SterilisationValidationQualification (1)
47/49
Manufacture of sterile medicines Advanced workshop for SFDA GMP
inspectors - Nanjin! Novem"er #$$%47
Ot"er Sterilization 'rocesses
?asses and .umi$ants *;+
)em#erature distribution is acce#table
(oncentration of sterilant $as is sufficient
@se of biolo$ical indicators is im#ortant
*Bacillus atropheus+
%alf cycles If cycle of "alf normal time destroys biolo$ical indicators */01
or$anisms+, double time will ac"ieve S23 of /0 -1
2eration
6entilated conditions Defined limits of residuals
'rocess included in validation
Safety and to&icity issues considered
@seful 'ublications
-
7/26/2019 1-2 SterilisationValidationQualification (1)
48/49
Manufacture of sterile medicines Advanced workshop for SFDA GMP
inspectors - Nanjin! Novem"er #$$%48
@seful 'ublications
ISOG:5 /H11C - Sterilization of health care
products - Moist Heat *'arts / and ;+
ISOG:5 ///C - Sterilization of health care
products - Ethylene Oxide *'arts / and ;+
ISOG:5 ///H - Sterilization of health care
products - Radiation *'arts /,; and +
alidation of Moist Heat Sterilization !rocesses"
#ycle $esi%n& $e'elopment& (ualification and
on%oin% #ontrol)'D2 )ec"nical Re#ort 5o= /
Revised ;00H
-
7/26/2019 1-2 SterilisationValidationQualification (1)
49/49
Manufacture of sterile medicines Advanced workshop for SFDA GMP
uestions